US Bancorp’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

US Bancorp’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12	Closed	–	–	3852
2015 Q3	$0	Hold	12	–	–	﹤0.01%	3828
2015 Q2	$0	Hold	12	–	–	﹤0.01%	3750
2015 Q1	$0	Hold	12	–	–	﹤0.01%	3712
2014 Q4	$0	Hold	12	–	–	﹤0.01%	3718
2014 Q3	$0	Buy	+12	New	+$119	﹤0.01%	3646

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $518M AUM 17.96% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

US Bancorp's RCPI Position: Q4 2015 in Review

US Bancorp sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 12 shares.

US Bancorp first reported a position in RCPI in Q3 2014 and held it in 5 quarters. The position peaked at $0 in Q3 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

US Bancorp reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
US Bancorp sold 12 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
US Bancorp first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 5 quarters.
US Bancorp's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q3 2015.
9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on US Bancorp's 13F filing for Q4 2015, filed 10 Feb 2016.